Mobile Stroke Units and Pursuit of Intravenous Tissue-Type Plasminogen Activator Treatment in the Golden Hour
Stroke · 2023-02 · 54 (2) · 426-429
DOI: 10.1161/strokeaha.122.041391 ↗Kurz gefasst
Editorial in der Zeitschrift Stroke, 2023-02. Verfasst von Kanta Tanaka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan (K.T.). Hauptthemen laut MEDLINE: Stroke, Brain Ischemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan (K.T.).
- Department of Epidemiology and Biostatistics, Michigan State University, East Lansing (M.J.R.).
ORCID-Profile: Kanta Tanaka, Mathew J Reeves
Zitieren
APA
Tanaka, K., & Reeves, M. J. (2023). Mobile Stroke Units and Pursuit of Intravenous Tissue-Type Plasminogen Activator Treatment in the Golden Hour. Stroke, 54(2), 426-429. https://doi.org/10.1161/strokeaha.122.041391
Vancouver
Tanaka K, Reeves MJ. Mobile Stroke Units and Pursuit of Intravenous Tissue-Type Plasminogen Activator Treatment in the Golden Hour. Stroke. 2023;54(2):426-429. doi:10.1161/strokeaha.122.041391
BibTeX
@article{Tanaka2023,
author = {Tanaka, Kanta and Reeves, Mathew J},
title = {Mobile Stroke Units and Pursuit of Intravenous Tissue-Type Plasminogen Activator Treatment in the Golden Hour},
journal = {Stroke},
year = {2023},
volume = {54},
number = {2},
pages = {426--429},
doi = {10.1161/strokeaha.122.041391}
}
EUVIMED